Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 20, Number 9—September 2014

Spread of Vaccinia Virus to Cattle Herds, Argentina, 2011

On This Page
Article Metrics
citations of this article
EID Journal Metrics on Scopus

Cite This Article

To the Editor: Since 1999, several zoonotic outbreaks of vaccinia virus (VACV) infection have been reported in cattle and humans in rural areas of Brazil. The infections have caused exanthematous lesions on cows and persons who milk them, and thus are detrimental to the milk industry and public health services (1,2). In Brazil during the last decade, VACV outbreaks have been detected from the north to the extreme south of the country (14). Because Brazil shares extensive boundaries with other South American countries, humans and cattle on dairy and beef-producing farms in those countries may be at risk of exposure to VACV. To determine if VACV has spread from Brazil to Argentina, we investigated the presence of VACV in serum samples from cattle in Argentina.

During 2011, we obtained serum samples from 100 animals (50 dairy and 50 beef cattle) on farms in Córdoba, Corrientes, Entre Ríos, and Santa Fe Provinces in Argentina (Technical Appendix, panel A). No VACV cases had been reported in humans or cattle in these provinces. However, Corrientes Province borders the Brazilian state of Rio Grande do Sul, where VACVs (Pelotas 1 and Pelotas 2 viruses) were isolated during an outbreak affecting horses in 2008 (2).

To determine the presence of neutralizing antibodies in the serum samples, we used an orthopoxvirus 70% plaque-reduction neutralization test as described (4). On the basis of previous studies that detected viral DNA in serum samples (46), we used real-time PCR to amplify the highly conserved orthopoxvirus vaccinia growth factor (vgf) gene DNA (P.A. Alves, unpub. methods).

To amplify the hemagglutinin (HA) gene DNA from the serum samples, we used real-time PCR with primers as described by de Souza Trindade et al. 2008 (7). The HA PCR products were directly sequenced in both orientations by using specific primers and capillary electrophoresis (Genetic Analyzer 3130; Applied Biosystems, Grand Island, NY, USA). We used ClustalW ( and MEGA4 software ( to align nucleotide sequences and construct a phylogenetic tree (neighbor-joining method, 1,000 bootstraps) from the obtained HA fragment.

Of the 50 dairy cattle samples, 4 (8.0%) had neutralizing antibodies against orthopoxvirus; of these, 3 (75.0%) had titers of 100 neutralizing units (NU)/mL, and 1 (25.0%) had a titer of 400 NU/mL. Of the 50 beef cattle, 8 (16.0%) had antibodies to orthopoxvirus, 1 (12.5%) of which had a titer of 800 NU/mL. Most of the positive samples were from cattle in Corrientes and Entre Ríos Provinces (Table).

Of the 100 serum samples, 5 (3 from beef and 2 from dairy cattle) were positive for vgf by real-time PCR. HA DNA was amplified from 2 of the 3 vgf PCR–positive beef cattle samples; plaque-reduction neutralization test results were also positive for the 2 samples (Table).

Alignment of the HA fragment nucleotide sequence of the isolates from Argentina showed that the sequence was highly similar to that of the homologous gene of VACV isolates from Brazil. Furthermore, the sequences showed a signature deletion that is also present in the sequences of VACV isolates from Brazil. Compared with sequences for other VACV isolates, those from Argentina had 2 polymorphisms (Technical Appendix, panel C). The HA sequences from the isolates from Argentina demonstrated 100% identity among themselves and exhibited higher identity with group 1 (98.2% identity) versus group 2 (93.6% identity) isolates from Brazil (Technical Appendix, panel D). In the phylogenetic tree based on the HA nucleotide sequences (Technical Appendix, panel B), the VACVs from Argentina clustered with several group 1 VACVs detected during outbreaks in Brazil.

Although no outbreaks of exanthematous VACV infection have been described in cattle or humans in Argentina, we detected neutralizing antibodies against orthopoxvirus and detected VACV DNA in serum samples from cattle in the country. Most of the seropositive samples were from cattle in Entre Ríos Province, which shares a border with Uruguay, and Corrientes Province, which shares a border with Rio Grande do Sul State in Brazil, where Pelotas VACVs have been isolated (2).

We believe that the seropositive cattle in this study may have been exposed to VACV, the only orthopoxvirus known to be circulating in South America (14,810). Despite veterinary surveillance efforts of border control organizations, VACV control may be hampered by the circulation of infected rural workers and the misdiagnosis of VACV infection; misdiagnoses occur because VACV lesions resemble those of other exanthematous diseases. Moreover, peridomestic rodents have been hypothesized to act as VACV hosts, and could facilitate the spread of VACV in border areas (10). In addition, we could not rule out the circulation of autochthonous VACV in Argentina, but this is a less likely explanation. Our findings suggest that cattle herds in areas of Argentina near the border with Brazil may be exposed to VACV from Brazil and, thus, may be at risk for VACV infection. Further research is needed to determine the risk factors for VACV infection and to assess the circulation of VACV in South America



We thank João Rodrigues dos Santos, Ângela Sana Lopes, Ilda Gama, and colleagues from the Laboratório de Vírus for their excellent technical support.

Financial support was provided by the Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), Fundação de Amparo à Pesquisa do Estado de Minas Gerais (FAPEMIG), and Ministério da Agricultura, Pecuária e Abastecimento (MAPA). A.P.M. F.-L. was the recipient of a fellowships from CAPES, and E.G.K., C.A.B., G.S.T., and P.C.P.F. were recipients of fellowships from CNPq.


Ana Paula Moreira Franco-Luiz, Alexandre Fagundes-Pereira, Galileu Barbosa Costa, Pedro Augusto Alves, Danilo Bretas Oliveira, Cláudio Antônio Bonjardim, Paulo César Peregrino Ferreira, Giliane de Souza Trindade, Carlos Javier Panei, Cecilia Mónica Galosi, Jônatas Santos Abrahão, and Maurício Teixeira LimaComments to Author 
Author affiliations: Universidade Federal de Minas Gerais, Belo Horizonte, Brazil (A.P.M. Franco-Luiz, A. Fagundes-Pereira, G.B. Costa, P.A. Alves, D.B. Oliveira, C.A. Bonjardim, P.C.P. Ferreira, G.S. Trindade, J.S. Abrahão, E.G. Kroon); Universidad Nacional de la Plata, Buenos Aires, Argentina (C.J. Panei, C.M. Galosi); Consejo Nacional Investigaciones Científicas y Técnicas, Buenos Aires (C.J. Panei); Comisión de Investigaciones Científicas Provincia de Buenos Aires,, Buenos Aires (C.M. Galosi)



  1. Trindade  GS, Lobato  ZIP, Drumond  BP, Leite  JA, Trigueiro  RC, Guedes  MIMC, Isolation of two vaccinia virus strains from a single bovine vaccinia outbreak in rural area from Brazil: implications on the emergence of zoonotic orthopoxviruses. Am J Trop Med Hyg. 2006;75:48690 .PubMedGoogle Scholar
  2. Campos  RK, Brum  MC, Nogueira  CE, Drumond  BP, Alves  PA, Siqueira-Lima  L, Assessing the variability of Brazilian vaccinia virus isolates from a horse exanthematic lesion: coinfection with distinct viruses. Arch Virol. 2011;156:27583. DOIPubMedGoogle Scholar
  3. Mota  BEF, Trindade  GS, Diniz  TC, da Silva-Nunes  M, Braga  EM, Urbano-Ferreira  M, Seroprevalence of orthopoxvirus in an Amazonian rural village, Acre, Brazil. Arch Virol. 2010;155:113944. DOIPubMedGoogle Scholar
  4. Abrahão  JS, Silva-Fernandes  AT, Lima  LS, Campos  RK, Guedes  MI, Cota  MM, Vaccinia virus infection in monkeys, Brazilian Amazon. Emerg Infect Dis. 2010;16:9769. DOIPubMedGoogle Scholar
  5. Cohen  JI, Hohman  P, Preuss  JC, Li  L, Fischer  SH, Fedorko  DP, Detection of vaccinia virus DNA, but not infectious virus, in the blood of smallpox vaccine recipients. Vaccine. 2007;25:45714. DOIPubMedGoogle Scholar
  6. Savona  MR, Dela Cruz  WP, Jones  MS, Thornton  JA, Xia  D, Hadfield  TL, Detection of vaccinia DNA in the blood following smallpox vaccination. JAMA. 2006;295:1895900. DOIPubMedGoogle Scholar
  7. de Souza Trindade  G, Li  Y, Olson  VA, Emerson  G, Regnery  RL, da Fonseca  FG, Real-time PCR assay to identify variants of vaccinia virus: implications for the diagnosis of bovine vaccinia in Brazil. J Virol Methods. 2008;152:6371. DOIPubMedGoogle Scholar
  8. Damon  IK. Poxviruses. In: Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, et al., editors. Fields virology. Vol II. 5th ed. Philadelphia: Lippincott Williams and Wilkins; 2007. p. 2947–75.
  9. Trindade  GS, Emerson  GL, Carroll  DS, Kroon  EG, Damon  IK. Brazilian vaccinia viruses and their origins. Emerg Infect Dis. 2007;13:96572. DOIPubMedGoogle Scholar
  10. Abrahão  JS, Guedes  MI, Trindade  GS, Fonseca  FG, Campos  RK, Mota  BF, One more piece in the VACV ecological puzzle: could peridomestic rodents be the link between wildlife and bovine vaccinia outbreaks in Brazil? PLoS ONE. 2009;4:e7428. DOIPubMedGoogle Scholar




Cite This Article

DOI: 10.3201/eid2009.140154

Related Links


Table of Contents – Volume 20, Number 9—September 2014

EID Search Options
presentation_01 Advanced Article Search – Search articles by author and/or keyword.
presentation_01 Articles by Country Search – Search articles by the topic country.
presentation_01 Article Type Search – Search articles by article type and issue.



Please use the form below to submit correspondence to the authors or contact them at the following address:

Erna G. Kroon, Laboratório de Vírus, Departamento de Microbiologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Av. Antônio Carlos, 6627, Caixa Postal 486, CEP 31270-901, Belo Horizonte, Minas Gerais, Brazil

Send To

10000 character(s) remaining.


Page created: August 18, 2014
Page updated: August 18, 2014
Page reviewed: August 18, 2014
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.